Isoprenoid Metabolism in Apicomplexan Parasites
Current clinical microbiology reports(2014)
摘要
Apicomplexan parasites include some of the most prevalent and deadly human pathogens. Novel antiparasitic drugs are urgently needed. Synthesis and metabolism of isoprenoids may present multiple targets for therapeutic intervention. The apicoplast-localized methylerythritol phosphate pathway for isoprenoid precursor biosynthesis is distinct from the mevalonate pathway used by the mammalian host, and this pathway is apparently essential in most Apicomplexa. In this review, we discuss the current field of research on production and metabolic fates of isoprenoids in apicomplexan parasites, including the acquisition of host isoprenoid precursors and downstream products. We describe recent work identifying the first methylerythritol phosphate pathway regulator in apicomplexan parasites, and introduce several promising areas for ongoing research into this well-validated antiparasitic target.
更多查看译文
关键词
apicomplexa,plasmodium,fosmidomycin,isoprenoid,metabolism,methylerythritol phosphate (mep) pathway,Apicomplexa,Plasmodium,Isoprenoid,Methylerythritol phosphate (MEP) pathway,Fosmidomycin,Metabolism
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要